-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics Reports Positive Phase 2 Results for QTORIN Rapamycin in Cutaneous Venous Malformations

Reuters·12/15/2025 11:00:33

Please log in to view news